KANSAI BIo-Venture View Interprotein Corporation


Interprotein Corporation

business:インタープロテイン株式会社

Interprotein is a drug discovery company focused on the discovery of small molecule drugs and structurally constrained peptide drugs, targeting protein-protein interactions (PPIs). For small-molecule drug discovery, we employ our proprietary technology INTENDD®, which is based on an algorithm that emphasizes shape complementarity. The basis of our peptide drug discovery is helix-loop-helix peptide, a new peptide modality invented by Professor Ikuo Fujii of Osaka Prefecture University. In 2016, we have initiated the development of AI-based drug discovery program that integrates INTENDD® and deep learning in collaboration with AI Squared, Inc. We are working towards changing the existing paradigm of drug discovery by achieving accurate activity prediction using the highest-precision AI. Our ultimate goal is to realize the development of small molecule drugs with our AI technology that does not require chemical libraries.

Field of business:Therapeutis

nameInterprotein Corporation
presidentMasato Hosoda
zip code531-0072
address#704, I&F Uneda 3-10-2, Toyosaki, Kita-ku, Osaka city
tel+81-6-6374-5303fax+81-6-6374-5305
urlhttp://www.interprotein.com
establishment1/May/2001
capital¥376,953,000 employees9

registration:2017-09-22 13:14:05 (These information might have changed after registration.)




keyword

Region

Field

Organizer
Kinki bio-industry development organization
Contact
TEL: +81-6-4963-2107 FAX:+81-6-4963-2127
3F No.2 Imonkawaramachi Building
4-8-4, Kawaramachi, Chuo-ku, Osaka Japan
Postal Code:541-0048

ページトップへ